Article
Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans
28 Oct 2020
Abstract excerpt
Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (allo-HCT) has a dismal prognosis. We found that T cells of patients relapsing with AML after allo-HCT exhibited reduced glycolysis and interferon-γ production. Functional studies in multiple mouse models of leukemia showed that leukemia-derived lactic acid (LA) interfered with T cell glycolysis and proliferation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
